4/A

PRIMARY DOCUMENT

Company: RIGEL PHARMACEUTICALS INC
Filed: March 23, 2004
Period of Report: February 19, 2004
Accession Number: 0001018534-04-000004

View Document ↗ View on SEC.gov ↗